Li-Fraumeni syndrome, a condition caused by a germline mutation in TP53 in humans born with a single mutant allele of TP53, encompasses a wide variety of early onset cancers, including AML in around 5% of Li Fraumeni related malignancies [10]. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.